Human albumin (Hebei Da'an Pharmaceutical)

人血白蛋白(河北大安制药)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman albumin (Hebei Da'an Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionSerum albumin agonists
TargetsSerum albumin
Therapy Area/IndicationsShock, HemorrhagicFibrosisRespiratory Distress Syndrome, Adult
Global Approved IndicationsShock, HemorrhagicFibrosisRespiratory Distress Syndrome, Adult
Approved Indications in ChinaShock, HemorrhagicFibrosisRespiratory Distress Syndrome, Adult
Original Approved Country/TerritoryMainland China
Original Approved Date2002/01/31
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsShock, HemorrhagicFibrosisRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeB05AA01